Palantir Technologies Inc.'s TITAN production award and expanding Maven deployments improve government revenue visibility.

Femasys is a commercial-stage medtech company targeting OB/GYNs with in-office fertility and permanent birth control ...

Trio-Tech (TRT) rating upgraded to Hold after a 47.5% drop. At $5.67, TRT trades at 0.59x EV/Sales. Read here for a detailed ...

Eastman Chemical's operational improvements contrast with market pessimism and a depressed 7-8x P/E multiple. See why EMN ...

ServiceNow remains a Strong Buy as its thesis holds, despite a recent valuation rebound driven by external AI lab ...

Microsoft Azure faces reported 20% cost-cutting talks amid rising AI infrastructure costs and talent competition.

Regions Financial Corporation Series C preferred offers low duration exposure and a 5.70% fixed coupon, transitioning to SOFR ...

The following slide deck was published by Biomea Fusion, Inc. in conjunction with this event.

American Tower (AMT) stock is buy-rated: global tower scale, strong cell-tower demand, and dividend growth. Read here for a ...

Kolibri Global (KGEI) stock's H1 2026 production surge from Lower Caney, key catalysts ahead (Clifton Mack, False Caney).

Alpine Income Property (PINE) rated Buy: 12.3% dividend hike, 7.1% yield, and portfolio growth—plus key Treasury/Fed risks.

Nu Holdings (NU) stock rebounds 20% on Brazil election sentiment; valuation now looks stretched. Read here for a detailed ...